Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Frequency of long-term nonprogressors in HIV-1 seroconverters From Rakai Uganda.

Laeyendecker O, Redd AD, Lutalo T, Gray RH, Wawer M, Ssempijja V, Gamiel J, Bwanika JB, Makumbi F, Nalugoda F, Opendi P, Kigozi G, Ndyanabo A, Iga B, Kiwanuka N, Sewankambo N, Reynolds SJ, Serwadda D, Quinn TC.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):316-9. doi: 10.1097/QAI.0b013e3181bc08f5.

2.

Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort.

Madec Y, Boufassa F, Avettand-Fenoel V, Hendou S, Melard A, Boucherit S, Surzyn J, Meyer L, Rouzioux C; ANRS SEROCO/HEMOCO Study Group.

J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):19-26. doi: 10.1097/QAI.0b013e31818ce709.

PMID:
19295331
3.

Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.

Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, Costagliola D.

AIDS. 2009 Jun 1;23(9):1163-9. doi: 10.1097/QAD.0b013e32832b44c8.

PMID:
19444075
4.

[Characteristics of long-term non-progressors and HIV controllers among HIV-infections in Henan, China].

Liu J, Fan PY, Xue XJ, Sun DY, Sun GQ, Liu CH, Tian SA, Li N, Zhu Q, Wang Z.

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Feb;37(2):227-31. doi: 10.3760/cma.j.issn.0254-6450.2016.02.016. Chinese.

PMID:
26917521
5.

C-reactive protein levels increase during HIV-1 disease progression in Rakai, Uganda, despite the absence of microbial translocation.

Redd AD, Eaton KP, Kong X, Laeyendecker O, Lutalo T, Wawer MJ, Gray RH, Serwadda D, Quinn TC; Rakai Health Sciences Program.

J Acquir Immune Defic Syndr. 2010 Aug;54(5):556-9. doi: 10.1097/QAI.0b013e3181e0cdea.

6.

Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.

Lefrère JJ, Morand-Joubert L, Mariotti M, Bludau H, Burghoffer B, Petit JC, Roudot-Thoraval F.

Blood. 1997 Aug 1;90(3):1133-40.

7.

Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010.

Mandalia S, Westrop SJ, Beck EJ, Nelson M, Gazzard BG, Imami N.

PLoS One. 2012;7(2):e29844. doi: 10.1371/journal.pone.0029844. Epub 2012 Feb 20.

8.

HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda.

Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, Kigozi G, Kagaayi J, Serwadda D, Makumbi FE, Reynolds SJ, Gray RH.

AIDS. 2009 Nov 27;23(18):2479-84. doi: 10.1097/QAD.0b013e328330cc08.

9.

Immunoregulatory T cells may be involved in preserving CD4 T cell counts in HIV-infected long-term nonprogressors and controllers.

Gaardbo JC, Ronit A, Hartling HJ, Gjerdrum LM, Springborg K, Ralfkiær E, Thorsteinsson K, Ullum H, Andersen ÅB, Nielsen SD.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):10-8. doi: 10.1097/QAI.0b013e3182a7c932.

PMID:
23995946
10.

Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial.

Reynolds SJ, Makumbi F, Newell K, Kiwanuka N, Ssebbowa P, Mondo G, Boaz I, Wawer MJ, Gray RH, Serwadda D, Quinn TC.

Lancet Infect Dis. 2012 Jun;12(6):441-8. doi: 10.1016/S1473-3099(12)70037-3. Epub 2012 Mar 19.

11.

Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort.

Thiébaut R, Matheron S, Taieb A, Brun-Vezinet F, Chêne G, Autran B; immunology group of the ANRS CO5 HIV-2 cohort.

AIDS. 2011 Mar 27;25(6):865-7. doi: 10.1097/QAD.0b013e328344892e.

PMID:
21358376
12.

Characteristics of Long-term Nonprogressors and Viremia Controllers Infected with HIV-1 via Contaminated Blood Donations or Transfusions Conducted 20 Years Earlier.

Liu J, Fan PY, Xue XJ, Yan JZ, Sun GQ, Liu CH, Tian SA, Li N, Sun DY, Zhu Q, Wang Z.

Biomed Environ Sci. 2017 Dec;30(12):907-912. doi: 10.3967/bes2017.121.

13.

Adipogenic/lipid, inflammatory, and mitochondrial parameters in subcutaneous adipose tissue of untreated HIV-1-infected long-term nonprogressors: significant alterations despite low viral burden.

Vidal F, Domingo P, Villarroya F, Giralt M, López-Dupla M, Gutiérrez M, Gallego-Escuredo JM, Peraire J, Viladés C, Veloso S, Mateo G, Guallar JP, Richart C.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):131-7.

PMID:
22580565
14.

Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors.

Rusconi S, Berlusconi A, Papagno L, Colombo MC, De Maddalena C, Riva A, Bagnarelli P, Balotta C, Galli M.

Clin Immunol Immunopathol. 1997 Dec;85(3):320-3.

15.

Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors.

Sankaran S, Guadalupe M, Reay E, George MD, Flamm J, Prindiville T, Dandekar S.

Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9860-5. Epub 2005 Jun 24.

16.

Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.

Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, Ganesan A, Hale B, Crum-Cianflone N, Delmar J, Barthel V, Quinnan G, Agan BK, Dolan MJ; Infectious Disease Clinical Research Program (IDCRP) HIV Working Group.

J Infect Dis. 2009 Dec 1;200(11):1714-23. doi: 10.1086/646609.

PMID:
19852669
17.

Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors.

Gaardbo JC, Hartling HJ, Ronit A, Thorsteinsson K, Madsen HO, Springborg K, Gjerdrum LM, Birch C, Laye M, Ullum H, Andersen ÅB, Nielsen SD.

PLoS One. 2013 May 16;8(5):e63744. doi: 10.1371/journal.pone.0063744. Print 2013.

18.

HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.

Eller MA, Opollo MS, Liu M, Redd AD, Eller LA, Kityo C, Kayiwa J, Laeyendecker O, Wawer MJ, Milazzo M, Kiwanuka N, Gray RH, Serwadda D, Sewankambo NK, Quinn TC, Michael NL, Wabwire-Mangen F, Sandberg JK, Robb ML.

J Infect Dis. 2015 May 15;211(10):1574-84. doi: 10.1093/infdis/jiu646. Epub 2014 Nov 17.

19.

Pediatric HIV Long-Term Nonprogressors.

Rimawi BH, Rimawi RH, Micallef M, Pinckney L, Fowler SL, Dixon TC.

Case Rep Infect Dis. 2014;2014:752312. doi: 10.1155/2014/752312. Epub 2014 Aug 26.

20.

How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS)

Petrucci A, Dorrucci M, Alliegro MB, Pezzotti P, Rezza G, Sinicco A, Lazzarin A, Angarano G.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Mar 1;14(3):243-8.

PMID:
9117457

Supplemental Content

Support Center